Bellevue Life Sciences Acquisition Corp.

Equities

BLAC

US0791741087

Investment Holding Companies

Market Closed - Nasdaq 21:30:00 22/05/2024 BST 5-day change 1st Jan Change
10.73 USD 0.00% Intraday chart for Bellevue Life Sciences Acquisition Corp. -0.65% +2.19%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Bellevue Life Sciences Acquisition Corp. announced that it has received $0.14 million in funding CI
Bellevue Life Sciences Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Bellevue Life Sciences Acquisition Corp. announced that it has received $0.05 million in funding CI
Bellevue Life Sciences Acquisition Corp. announced that it has received $1.2 million in funding CI
Bellevue Life Sciences Acquisition Corp. announced that it has received $0.06 million in funding CI
Bellevue Life Sciences Acquisition Corp. announced that it has received $0.075 million in funding CI
Bellevue Life Sciences Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Bellevue Life Sciences Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Certain Common Stock of Bellevue Life Sciences Acquisition Corp. are subject to a Lock-Up Agreement Ending on 9-AUG-2023. CI
Bellevue Life Sciences Acquisition Plans to Take OSR Holdings Public in SPAC Merger Deal MT
Bellevue Life Sciences Acquisition Corp. entered into an exclusive, non-binding letter of intent to acquire OSR Holdings, Ltd. CI
Bellevue Life Sciences Acquisition Corp. announced that it has received $0.2 million in funding CI
Bellevue Life Sciences Acquisition Corp. Announces the Resignation of Hosun Euh as Member of the Board of Directors, Effective June 21, 2023 CI
Bellevue Life Sciences Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Bellevue Life Sciences Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Bellevue Life Sciences Acquisition Corp. Auditor Raises 'Going Concern' Doubt CI
Bellevue Life Sciences Acquisition Corp.(NasdaqCM:BLAC) added to NASDAQ Composite Index CI
Bellevue Life Sciences Acquisition Corp. has completed an IPO in the amount of $60 million. CI
Bellevue Life Sciences Acquisition Corp. has filed an IPO in the amount of $60 million. CI
Chart Bellevue Life Sciences Acquisition Corp.
More charts
Bellevue Life Sciences Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The Company has not selected any business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The Company may pursue an acquisition opportunity in any business industry or sector. The Company intends to acquire and manage a business in the healthcare industry, more specifically in the biotechnology sector. The Company neither engaged in any operations nor generated any revenues.
More about the company
  1. Stock Market
  2. Equities
  3. BLAC Stock
  4. News Bellevue Life Sciences Acquisition Corp.
  5. Bellevue Life Sciences Acquisition Plans to Take OSR Holdings Public in SPAC Merger Deal